Etirinotecan pegol (NKTR-102) versus treatment of physician's choice in women with advanced breast cancer previously treated with an anthracycline, a taxane, and capecitabine (BEACON): a randomised, open-label, multicentre, phase 3 trial
scientific article published on 15 October 2015
Author/s
author: Javier Cortes, Chris Twelves, Hope Rugo, Denise A Yardley, Joyce O'Shaughnessy, Mary Tagliaferri, Edith A. Perez, Seock-Ah Im, Ute Hoch, Patricia Gómez-Pardo, Lee S Schwartzberg, Audrey Mailliez, Alvaro Moreno-Aspitia, Jin-Seok Ahn, Alison L Hannah
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.